Bevacizumab 2 recalled over sterility concerns
- Recall date
- May 3, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Avella of Deer Valley, Inc. Store 38 recalls Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE PHO…
- Recall number
- D-1308-2019
- FDA classification
- Class II
- Brand / firm
- Avella of Deer Valley, Inc. Store 38
- Sold / distributed
- U.S.A. nationwide
Why it was recalled
Lack of assurance of sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE PHOENIX, AZ 85085, NDC 42852-001-27
Get recall alerts
Free email alert whenever Avella of Deer Valley, Inc. Store 38 has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Avella of Deer Valley, Inc. Store 38